The Potential of Human iPSC-Heart Cells in Fentanyl Opioid Research
Recent studies utilizing human iPSC-derived cardiomyocytes reveal fentanyl’s detrimental effects on heart rhythm, providing new insights into overdose-related cardiac risks and potential for personalized research approaches.
Fentanyl, a potent synthetic opioid that is 50 to 100 times stronger than morphine, has become a significant contributor to the ongoing opioid crisis. Its overdose effects include severe respiratory depression and, notably, cardiac arrest. While opioid-related arrhythmias are known, the specific impacts of fentanyl on heart rhythm have yet to be thoroughly examined.
Recent research published in Circulation by researchers from Stanford Cardiovascular Institute highlights the groundbreaking use of human-induced pluripotent stem cell (iPSC) derived heart cells to study fentanyl’s cardiac effects. Led by first-author Gema Mondéjar-Parreño, Ph.D., and senior author Joseph C. Wu, MD, Ph.D., the study leverages patient-specific iPSC-cardiomyocytes to analyze electrophysiological changes induced by fentanyl.
The researchers analyzed 19 toxicology studies conducted between 1994 and 2022, which indicated fentanyl concentrations in overdose scenarios were approximately three times higher than therapeutic doses used in chronic pain management. In the lab, iPSC-derived cardiomyocytes were exposed to fentanyl doses simulating overdose conditions. The results revealed significant disruptions in calcium signaling—a vital process for heart muscle contractions—and a slowing of the cells' readiness for the next beat, leading to irregular heart rhythms.
Moreover, the study demonstrated that when combined with isoproterenol, a drug that increases heart rate, fentanyl-induced arrhythmias worsened, suggesting that heightened sympathetic stimulation can aggravate fentanyl's cardiac effects.
This research provides critical evidence that fentanyl impairs cardiac cell function, leading to rhythm disturbances that can precipitate sudden cardiac events. These electrophysiological alterations, coupled with respiratory depression, underscore fentanyl’s high risk for causing cardiac arrest especially in overdose cases.
Further investigations are essential to deepen our understanding of fentanyl’s impact on cardiac electrophysiology and to develop targeted strategies for preventing fentanyl-related cardiac emergencies. The innovative use of human iPSC-cardiomyocytes offers a promising avenue for personalized medicine and safer therapeutic interventions in the future.
Source: https://medicalxpress.com/news/2025-08-exploring-human-ipsc-heart-cells.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Emerging Research Finds Electric Brain Stimulation Can Enhance Mathematical Abilities
Research shows that mild electrical stimulation of the brain can improve math skills, particularly in individuals with weaker neural connections, offering new hope for cognitive enhancement and learning support.
Innovative AI-Based Voice Analysis Promises Early Detection of Throat Cancers
A new AI-powered voice analysis tool developed by Emory University offers a promising method for early detection of throat and laryngeal cancers, potentially saving lives through timely intervention.
Brain Power and Cognitive Skills in Hockey: Position-Specific Brain Processing Revealed by Study
Recent research reveals that hockey players' cognitive processing speeds vary by position, and targeted brain training can enhance their performance and safety on the ice. Using portable neurotechnology, athletes can now measure and improve neural responses for better reaction times and decision-making.
FDA Approves First Medication for Chronic Lung Disease Bronchiectasis
The FDA has approved Brinsupri, the first medication specifically targeting non-cystic fibrosis bronchiectasis, offering new hope for patients with this chronic lung condition.